Sarah Ruwe
About Sarah Ruwe
Sarah Ruwe is a Senior Clinical Project Manager at Mirum Pharmaceuticals, specializing in oncology and biotechnology clinical trials. With extensive experience in various roles within the clinical research field, she has worked for notable companies including Seattle Genetics and PSI CRO AG.
Work at Mirum Pharmaceuticals
Sarah Ruwe has been serving as a Senior Clinical Project Manager at Mirum Pharmaceuticals since 2021. In this role, she manages clinical trials with a specific focus on oncology and biotechnology. Her responsibilities include overseeing project timelines, ensuring compliance with regulatory standards, and coordinating with various stakeholders to facilitate successful trial outcomes.
Previous Experience in Clinical Project Management
Prior to her current position, Sarah Ruwe held several roles in clinical project management. She worked at PSI CRO AG as a Clinical Project Manager from 2019 to 2021, and briefly as a Lead Clinical Project Manager in 2021. She also served as a Clinical Project Lead at Syneos Health from 2018 to 2019. Her extensive experience in these roles has contributed to her expertise in managing complex clinical trials.
Experience at Seattle Genetics
Sarah Ruwe has a significant history with Seattle Genetics, where she worked in various capacities from 2009 to 2018. She started as a Clinical Research Associate II, then progressed to roles such as Clinical Project Manager and Clinical Trial Manager. Her tenure at Seattle Genetics provided her with a strong foundation in clinical research and project management within the oncology sector.
Educational Background
Sarah Ruwe studied at the University of Washington from 1997 to 2000. This educational background has equipped her with the necessary knowledge and skills to excel in the clinical research field, particularly in managing clinical trials and understanding regulatory requirements.
Skills and Expertise
Sarah Ruwe possesses strong skills in Electronic Data Capture (EDC) and Clinical Data Management. She is experienced in adhering to Good Clinical Practice (GCP) standards, which are essential for ensuring the integrity and quality of clinical trials in the pharmaceuticals industry. Her expertise in oncology and biotechnology further enhances her capability in managing complex clinical projects.